7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Dramatic Recovery of a Patient with Biguanide-associated Severe Lactic Acidosis Following Thiamine Supplementation

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Biguanides are a drug of choice for the treatment of type 2 diabetes mellitus. Although they can cause lactic acidosis in susceptible patients with predisposing risk factors, the incidence of lactic acidosis is reported to be very low when they are used properly. We herein present a case of biguanide-associated severe lactic acidosis complicated with thiamine deficiency that was provoked without predisposing factors for thiamine deficiency. Diabetic patients taking biguanide may be predisposed to thiamine deficiency, even when there is no evidence of risk factors, and the high-dose administration of thiamine may be essential in the treatment of this otherwise under-recognized disorder.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: not found
          • Article: not found

          Lactic acidosis.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

            Metformin is widely viewed as the best initial pharmacological option to lower glucose concentrations in patients with type 2 diabetes mellitus. However, the drug is contraindicated in many individuals with impaired kidney function because of concerns of lactic acidosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Lactic acidosis update for critical care clinicians.

              F C Luft (2001)
              Lactic acidosis is a broad-anion gap metabolic acidosis caused by lactic acid overproduction or underutilization. The quantitative dimensions of these two mechanisms commonly differ by 1 order of magnitude. Overproduction of lactic acid, also termed type A lactic acidosis, occurs when the body must regenerate ATP without oxygen (tissue hypoxia). Circulatory, pulmonary, or hemoglobin transfer disorders are commonly responsible. Overproduction of lactate also occurs with cyanide poisoning or certain malignancies. Underutilization involves removal of lactic acid by oxidation or conversion to glucose. Liver disease, inhibition of gluconeogenesis, pyruvate dehydrogenase (thiamine) deficiency, and uncoupling of oxidative phosphorylation are the most common causes. The kidneys also contribute to lactate removal. Concerns have been raised regarding the role of metformin in the production of lactic acidosis, on the basis of individual case reports. The risk appears to be considerably less than with phenformin and involves patients with underlying severe renal and cardiac dysfunction. Drugs used to treat lactic acidosis can aggravate the condition. NaHCO(3) increases lactate production. Treatment of type A lactic acidosis is particularly unsatisfactory. NaHCO(3) is of little value. Carbicarb is a mixture of Na(2)CO(3) and NaHCO(3) that buffers similarly to NaHCO(3) but without net generation of CO(2). The results from animal studies are promising; however, clinical trials are sparse. Dichloroacetate stimulates pyruvate dehydrogenase and improves laboratory values, but unfortunately not survival rates, among patients with lactic acidosis. Hemofiltration has been advocated for the treatment of lactic acidosis, on the basis of anecdotal experiences. However, kinetic studies of lactate removal do not suggest that removal can counteract lactate production in any meaningful way. The ideal treatment is to stop acid production by treating the underlying disorder.
                Bookmark

                Author and article information

                Journal
                Intern Med
                Intern. Med
                10.2169/internalmedicine.56.7754
                Internal Medicine
                The Japanese Society of Internal Medicine
                0918-2918
                1349-7235
                15 February 2017
                : 56
                : 4
                : 455-459
                Affiliations
                [1 ]Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan
                [2 ]Department of Emergency and Critical Care Medicine, Tohoku University Hospital, Japan
                [3 ]Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Japan
                Author notes

                Correspondence to Dr. Shigeo Godo, s-godo@ 123456cardio.med.tohoku.ac.jp

                Article
                5364202
                28202871
                f0d8c98c-611a-41fb-bb2b-7c4e02b4074e

                The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit ( https://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 24 May 2016
                : 10 June 2016
                Categories
                Case Report

                buformin,biguanide,lactic acidosis,thiamine deficiency
                buformin, biguanide, lactic acidosis, thiamine deficiency

                Comments

                Comment on this article